X0708 D/A LIVE 0001770069 Alvarado Therapeutics, Inc. 501 2nd Street San Francisco CA CALIFORNIA 94107 919-641-8778 DELAWARE None None Corporation true 2018 Christopher A Kroeger c/o Alvarado Therapeutics, Inc. 501 2nd Street San Francisco CA CALIFORNIA 94107 Executive Officer Director George Pavlov c/o Alvarado Therapeutics, Inc. 501 2nd Street San Francisco CA CALIFORNIA 94107 Director Robert Malenka c/o Alvarado Therapeutics, Inc. 501 2nd Street San Francisco CA CALIFORNIA 94107 Director James Lillie c/o Alvarado Therapeutics, Inc. 501 2nd Street San Francisco CA CALIFORNIA 94107 Executive Officer Peter A Bisgaard c/o Alvarado Therapeutics, Inc. 501 2nd Street San Francisco CA CALIFORNIA 94107 Director Jonathan Gillis c/o Alvarado Therapeutics, Inc. 501 2nd Street San Francisco CA CALIFORNIA 94107 Executive Officer Biotechnology Decline to Disclose 06b true 0001770069-19-000002 2019-02-22 false true true The underlying shares of common stock issuable upon conversion. false 0 5000000 5000000 0 false 2 0 0 0 false Alvarado Therapeutics, Inc. /s/ Christopher A. Kroeger Christopher A. Kroeger Chief Executive Officer 2019-03-21